Articles in Press: Clinical Lung Cancer

Skip to Main Content

ADVERTISEMENT

SCROLL TO CONTINUE WITH CONTENT

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Clinical Lung Cancer Home

Home
Articles & Issues
For Authors
Journal Info
Subscribe
Qualified Recipients
Related Journals
More Periodicals

Advanced searchSave search

Please enter a term before submitting your search.

Submit Article
Log in
Register
Log in
- Submit Article
- Log in
Subscribe
Claim

Current Issue
Articles in Press
Archive
- Archive

Select all

Please select at least one article in order to proceed.

March 23, 2023

Personalised Assessment and Rapid Intervention in Frail Patients with Lung Cancer: The Impact of an Outpatient Occupational Therapy Service

Personalised Assessment and Rapid Intervention in Frail Patients with Lung Cancer: The Impact of an Outpatient Occupational Therapy Service

J Welford,
R Rafferty,
D Short,
F Dewhurst,
A Greystoke

Published online: March 23, 2023

Full-Text HTML
PDF
Supplemental Materials

March 21, 2023

Letter to the Editor Reply: Kleebayoon et al.

Justin F. Gainor

Published online: March 21, 2023

Full-Text HTML
PDF

March 20, 2023

Correspondence on SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies

Amnuay Kleebayoon,
Viroj Wiwanitkit

Published online: March 20, 2023

Full-Text HTML
PDF

RELAY, Ramucirumab plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association between TP53 Status and Clinical Outcome

RELAY, Ramucirumab plus Erlotinib (RAM+ERL) in Untreated Metastatic EGFR-Mutant NSCLC (EGFR+ NSCLC): Association between TP53 Status and Clinical Outcome

Makoto Nishio,
Luis Paz-Ares,
Martin Reck,
...
Hillary T. Graham,
Carla Visseren-Grul,
Silvia Novello

Published online: March 20, 2023

Full-Text HTML
PDF
Supplemental Materials

Association between quality of life questionnaire at diagnosis and survival in patients with lung cancer

Association between quality of life questionnaire at diagnosis and survival in patients with lung cancer

Yu Jin Hong,
Solji Han,
Jeong Uk Lim,
...
Sang Haak Lee,
Seung Joon Kim,
Chang Dong Yeo

Published online: March 20, 2023

Open Access

Full-Text HTML
PDF
Supplemental Materials

A National Survey of Surgeons Evaluating the Accuracy of Mediastinal Lymph Node Identification

A National Survey of Surgeons Evaluating the Accuracy of Mediastinal Lymph Node Identification

Chi-Fu Jeffrey Yang,
Nirmal Veeramachaneni,
Jacob Hurd,
...
Nicholas Teman,
Sarah Blair,
Linda W. Martin

Published online: March 20, 2023

Full-Text HTML
PDF
Supplemental Materials

A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination with Carboplatin in Extensive Stage Small Cell Lung Cancer

A Brief Report of a Phase II trial Evaluating Efficacy and Safety of Hypomethylating Agent Guadecitabine in Combination with Carboplatin in Extensive Stage Small Cell Lung Cancer

Cynthia X. Wei,
Hirva Mamdani,
Ryan Gentzler,
...
Susan Perkins,
Sandra Althouse,
Shadia I Jalal

Published online: March 20, 2023

Full-Text HTML
PDF

March 19, 2023

Lobe-specific lymph node dissection may be feasible for clinical N0 solid-predominant part-solid lung adenocarcinoma with solid component diameter ≤2 cm

Lobe-specific lymph node dissection may be feasible for clinical N0 solid-predominant part-solid lung adenocarcinoma with solid component diameter ≤2 cm

Yang Wo,
Hang Li,
Zhencong Chen,
...
Ting Ye,
Wei Jiang,
Yihua Sun

Published online: March 19, 2023

Full-Text HTML
PDF
Supplemental Materials

March 18, 2023

Real-world Biomarker Testing Patterns in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in a US Community-based Oncology Practice Setting

Real-world Biomarker Testing Patterns in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) in a US Community-based Oncology Practice Setting

Anthony N. Sireci,
Peter M. Krein,
Lisa M. Hess,
...
Sandhya Bhaskar,
Ganiat Mumuney,
Anna Coutinho

Published online: March 18, 2023

Full-Text HTML
PDF

Factors Associated with Receipt of Molecular Testing and Its Impact On Time To Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer

Factors Associated with Receipt of Molecular Testing and Its Impact On Time To Initial Systemic Therapy in Metastatic Non-Small Cell Lung Cancer

Oyomoare L. Osazuwa-Peters,
Lauren E. Wilson,
Devon K. Check,
...
Vasanthi Mandhadi,
Alexander Stoddard,
Michaela A. Dinan

Published online: March 18, 2023

Full-Text HTML
PDF
Supplemental Materials

A patient-centered model of fast-track lung cancer diagnosis

A patient-centered model of fast-track lung cancer diagnosis

Pauline Pradere,
Caroline Caramella,
Fares Ben Salem,
...
Elie Fadel,
Jérôme Le Pavec,
Olaf Mercier

Published online: March 18, 2023

Full-Text HTML
PDF

Salvage surgery after first-line Alectinib for locally-advanced/metastatic ALK-rearranged NSCLC: pathological response and peri-operative results

Salvage surgery after first-line Alectinib for locally-advanced/metastatic ALK-rearranged NSCLC: pathological response and peri-operative results

Filippo Lococo,
Alessandra Cancellieri,
Marco Chiappetta,
...
Stefano Margaritora,
Marcello Tiseo,
Emilio Bria

Published online: March 18, 2023

Full-Text HTML
PDF

March 4, 2023

Reducing racial disparities in the timeliness of potential lung cancer evaluation with a novel application-supported rapid outpatient diagnostic program: An interrupted time series analysis

Reducing racial disparities in the timeliness of potential lung cancer evaluation with a novel application-supported rapid outpatient diagnostic program: An interrupted time series analysis

Ismini Kourouni,
Arvind Suguness,
James Finley,
Enambir Singh Josan,
Katherine Dutton,
Yasir Tarabichi

Published online: March 04, 2023

Full-Text HTML
PDF
Supplemental Materials

Tumor Volume is a Better Prognostic Factor than Greatest Tumor Diameter in operated Stage I-III Non-small Cell Lung Cancer

Tumor Volume is a Better Prognostic Factor than Greatest Tumor Diameter in operated Stage I-III Non-small Cell Lung Cancer

Ayşe Ocak Duran,
Mevlude Inanc,
Oktay Bozkurt,
Ersin Ozaslan,
Metin Ozkan

Published online: March 04, 2023

Full-Text HTML
PDF

March 3, 2023

Differences in VA and non-VA pulmonary nodules: All evaluations are not created equal

Differences in VA and non-VA pulmonary nodules: All evaluations are not created equal

Melissa L. New,
Erin A. Hirsch,
William J. Feser,
...
Kavita Garg,
York E. Miller,
Anna E. Baron

Published online: March 03, 2023

Full-Text HTML
PDF
Supplemental Materials

February 28, 2023

Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non–small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90%

Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non–small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90%

Mohsin Shah,
Ronac Mamtani,
Melina E. Marmarelis,
Sean Hennessy

Published online: February 28, 2023

Full-Text HTML
PDF
Supplemental Materials

February 27, 2023

The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

The EU-funded I³LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy

Arsela Prelaj,
Monica Ganzinelli,
Francesco Trovo’,
...
Enriqueta Felip,
Martin Reck,
Marina Chiara Garassino

Published online: February 27, 2023

Full-Text HTML
PDF

February 11, 2023

DUPLICATE: Cancers of the Pancreas Update 2023

Dr Jordan Berlin

Published online: February 11, 2023

PDF

February 8, 2023

Brief Report: EGFR L833V/H835L Duplex-Mutated NSCLC With Leptomeningeal Carcinomatosis Responsive to Osimertinib

Jarrod T. Smith,
Sonam Puri,
Wallace Akerley

Published online: February 08, 2023

Full-Text HTML
PDF

Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue Testing

Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue Testing

Miguel García-Pardo,
Inmaculada Aparicio,
Íñigo Martínez,
...
Mar Galera,
Rosa Álvarez,
Antonio Calles

Published online: February 08, 2023

Full-Text HTML
PDF

February 7, 2023

Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2

Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2

Yasuhiro Tsutani,
Jonathan W. Goldman,
Sanja Dacic,
...
Allen Chen,
Toon van der Gronde,
Jie He

Published online: February 07, 2023

Open Access

Full-Text HTML
PDF

A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer

A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non–Small Cell Lung Cancer

Wade T. Iams,
Meridith L. Balbach,
Sharon Phillips,
...
Jorge Nieva,
Tejas Patil,
D. Ross Camidge

Published online: February 07, 2023

Open Access

Full-Text HTML
PDF
Supplemental Materials

Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung Carcinoma: A Systematic Literature Review

Current and Emerging Treatment Options for Patients With Relapsed Small-cell Lung Carcinoma: A Systematic Literature Review

Reyes Bernabé-Caro,
Yuanbin Chen,
Afshin Dowlati,
Paula Eason

Published online: February 07, 2023

Open Access

Full-Text HTML
PDF
Supplemental Materials

Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

Melissa L. Johnson,
James Strauss,
Manish R. Patel,
...
Josée Morin,
Richard Chao,
Balazs Halmos

Published online: February 07, 2023

Full-Text HTML
PDF

Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis

Monika A. Izano,
Connor Sweetnam,
Chenan Zhang,
...
Mary Tran,
Thomas D. Brown,
Shirish M. Gadgeel

Published online: February 07, 2023

Open Access

Full-Text HTML
PDF
Supplemental Materials

February 6, 2023

Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer

Retrospective Study to Examine Prognostic Value of C-Reactive Protein in Patients With Surgically Resectable Non-Small-Cell Lung Cancer

Christopher Azzoli,
Lynn Huynh,
Denise Yi,
Mei S. Duh,
Beilei Cai

Published online: February 06, 2023

Full-Text HTML
PDF
Supplemental Materials

Thoracic Radiation in Limited Stage Small Cell Lung Cancer: Trends in Radiation Fractionation

Thoracic Radiation in Limited Stage Small Cell Lung Cancer: Trends in Radiation Fractionation

Mehdi Kazemi,
Colton Ladbury,
Jason Liu,
Scott Glaser,
Terence Williams,
Arya Amini

Published online: February 06, 2023

Full-Text HTML
PDF

January 31, 2023

A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small Cell Lung Cancer Study: (NEJ048A/NEXUS)

A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non–Small Cell Lung Cancer Study: (NEJ048A/NEXUS)

Akihiko Miyanaga,
Hajime Asahina,
Satoshi Watanabe,
...
Kotone Matsuyama,
Kunihiko Kobayashi,
Masahiro Seike

Published online: January 31, 2023

Open Access

Full-Text HTML
PDF

January 26, 2023

Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions

Liquid Biopsy Screening for Early Detection of Lung Cancer: Current State and Future Directions

William Zhu,
Kyra Love,
Stacy W. Gray,
Dan J. Raz

Published online: January 26, 2023

Full-Text HTML
PDF
Supplemental Materials

January 25, 2023

Association of Reported Candidate Monogenic Genes With Lung Cancer Risk

Association of Reported Candidate Monogenic Genes With Lung Cancer Risk

Andrew S. Rifkin,
Ethan M. Less,
Jun Wei,
...
Peter J. Hulick,
Seth B. Krantz,
Jianfeng Xu

Published online: January 25, 2023

Full-Text HTML
PDF
Supplemental Materials

Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies

Brief Report: Declining Rates of SARS-CoV-2 Vaccine Uptake Among Patients With Thoracic Malignancies

Catherine B. Meador,
Vivek Naranbhai,
Grace Hambelton,
...
Alejandro B. Balazs,
A. John Iafrate,
Justin F. Gainor

Published online: January 25, 2023

Full-Text HTML
PDF
Supplemental Materials

Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression

Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression

Misha C. Tran,
Garth W. Strohbehn,
Theodore G. Karrison,
...
Marina C. Garassino,
Everett E. Vokes,
Christine M. Bestvina

Published online: January 25, 2023

Open Access

Full-Text HTML
PDF
Supplemental Materials

January 24, 2023

Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy

Antibiotic Treatment is an Independent Poor Risk Factor in NSCLC But Not in Melanoma Patients Who had Received Anti-PD-1/L1 Monotherapy

Hannes Vihinen,
Artturi Jokinen,
Teemu D. Laajala,
...
Micaela Hernberg,
Maria Silvoniemi,
Kalle E. Mattila

Published online: January 24, 2023

Open Access

Full-Text HTML
PDF

January 20, 2023

Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC

Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC

Anna S. Krämer,
Sebastian Adeberg,
Dorothea Kronsteiner,
...
Stefan Rieken,
Jürgen Debus,
Rami A. El Shafie

Published online: January 20, 2023

Full-Text HTML
PDF

Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma

Prognostic Role of Biologically Active Volume of Disease in Patients With Metastatic Lung Adenocarcinoma

Colton Ladbury,
Tariq Abuali,
Jason Liu,
...
Terence Williams,
Scott Glaser,
Arya Amini

Published online: January 20, 2023

Full-Text HTML
PDF

The Association of Improved Overall Survival with NSAIDs in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

The Association of Improved Overall Survival with NSAIDs in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

Nikhil T. Sebastian,
William A. Stokes,
Madhusmita Behera,
...
Suresh S. Ramalingam,
Vikas P. Sukhatme,
Drew Moghanaki

Published online: January 20, 2023

Open Access

Full-Text HTML
PDF
Supplemental Materials

Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial

Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial

Andrea Riccardo Filippi,
Francesco Agustoni,
Stefano Arcangeli,
...
Paolo Pedrazzoli,
Umberto Malapelle,
Francesco Grossi

Published online: January 20, 2023

Full-Text HTML
PDF

Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade

Lung Immune Therapy Evaluation (LITE) Risk, a Novel Prognostic Model for Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Blockade

Vishal Navani,
Daniel E. Meyers,
Yibing Ruan,
...
Randeep Sangha,
Winson Y. Cheung,
Aliyah Pabani

Published online: January 20, 2023

Open Access

Full-Text HTML
PDF
Supplemental Materials

December 27, 2022

Comparison of Chemotherapy Plus Pembrolizumab vs. Chemotherapy Alone in EGFR-Mutant Non–small-Cell Lung Cancer Patients

Comparison of Chemotherapy Plus Pembrolizumab vs. Chemotherapy Alone in EGFR-Mutant Non–small-Cell Lung Cancer Patients

Minjiang Chen,
Yan Xu,
Jing Zhao,
...
Li Zhang,
Wei Zhong,
Mengzhao Wang

Published online: December 27, 2022

Open Access

Full-Text HTML
PDF
Supplemental Materials

Prevalence and Predictability of Occult Satellite Nodules in Clinical Stage Ia Non-small Cell Lung Cancer following Lobectomy

Prevalence and Predictability of Occult Satellite Nodules in Clinical Stage Ia Non-small Cell Lung Cancer following Lobectomy

Peter J. Kneuertz,
Mahmoud Abdel-Rasoul,
Desmond M. D'Souza,
Susan D. Moffatt-Bruce,
Robert E. Merritt

Published online: December 27, 2022

Full-Text HTML
PDF
Supplemental Materials

December 25, 2022

Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor)

Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor)

Bipin Ghimire,
Ashbita Pokharel,
Ujjwal Karki,
Shrinjaya Thapa,
Mohammad Muhsin Chisti

Published online: December 25, 2022

Full-Text HTML
PDF
Supplemental Materials

Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study

Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study

Lixian Ling,
Hongjuan Zheng,
Haiping Lin,
...
Yang Lou,
Ting Jiang,
Jianfei Fu

Published online: December 25, 2022

Full-Text HTML
PDF
Supplemental Materials

Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma

Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma

Lubna Suaiti,
Travis B. Sullivan,
Kimberly M. Rieger-Christ,
Elliot L. Servais,
Kei Suzuki,
Eric J. Burks

Published online: December 25, 2022

Full-Text HTML
PDF

December 24, 2022

Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data

Treatment Patterns and Outcomes in Resected Early-stage Non-small Cell Lung Cancer: An Analysis of the SEER-Medicare Data

Howard West,
Xiaohan Hu,
Su Zhang,
...
Anya Jiang,
James Signorovitch,
Ayman Samkari

Published online: December 24, 2022

Open Access

Full-Text HTML
PDF
Supplemental Materials

December 24, 2021

WITHDRAWN: Germline testing of patients with non-small cell lung cancers demonstrating incidentally uncovered BRCA2 apparent pathogenic germline variants

Steven Sorscher

Published online: December 24, 2021

PDF

November 10, 2020

WITHDRAWN: Progression patterns of metastatic lung adenocarcinoma patients with EGFR mutation

Shinichiro Okauchi,
Katsunori Kagohashi,
Toshihiro Shiozawa,
Kunihiko Miyazaki,
Hiroaki Satoh

Published online: November 10, 2020

PDF

Login to your account

Email/Username

Password

Forgot password?

Remember me

Don’t have an account?

Create a Free Account

If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

Email*

If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

The content on this site is intended for healthcare professionals.

We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.

Copyright © 2023 Elsevier Inc. except certain content provided by third parties.

Privacy Policy
Terms and Conditions
Accessibility
Help & Contact

RELX